Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis

To improve the transdermal bioavailability and safety of alendronate (ALN), a nitrogen-containing bisphosphonate, we developed self-dissolving microneedle arrays (MNs), in which ALN is loaded only at the tip portion of micron-scale needles by a dip-coating method (ALN(TIP)–MN). We observed micron-scale pores in rat skin just after application of ALN(TIP)–MN, indicating that transdermal pathways for ALN were created by MN. ALN was rapidly released from the tip of MNs as observed in an in vitro release study. The tip portions of MNs completely dissolved in the rat skin within 5 min after application in vivo. After application of ALN(TIP)–MN in mice, the plasma concentration of ALN rapidly increased, and the bioavailability of ALN was approximately 96%. In addition, the decrease in growth plate was effectively suppressed by this efficient delivery of ALN in a rat model of osteoporosis. Furthermore, no skin irritation was observed after application of ALN(TIP)–MN and subcutaneous injection of ALN, while mild skin irritation was induced by whole-ALN-loaded MN (ALN–MN)—in which ALN is contained in the whole of the micron-scale needles fabricated from hyaluronic acid—and intradermal injection of ALN. These findings indicate that ALN(TIP)–MN is a promising transdermal formulation for the treatment of osteoporosis without skin irritation.

[1]  Yuqin Qiu,et al.  Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. , 2013, International journal of pharmaceutics.

[2]  J. Mucklow,et al.  Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.

[3]  J. W. Wiechers,et al.  The barrier function of the skin in relation to percutaneous absorption of drugs , 1989, Pharmaceutisch Weekblad.

[4]  H. Katsumi,et al.  Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. , 2012, Journal of pharmaceutical sciences.

[5]  P. Acott,et al.  Determination of pamidronate in human whole blood and urine by reversed-phase HPLC with fluorescence detection. , 2004, Biomedical chromatography : BMC.

[6]  T Nakagawa,et al.  A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.

[7]  H. Wulf,et al.  Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. , 2003, Acta dermato-venereologica.

[8]  Mark R Prausnitz,et al.  Dissolving microneedle patch for transdermal delivery of human growth hormone. , 2011, Small.

[9]  Robert Stern,et al.  Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications , 2006, Biotechnology Letters.

[10]  Babak Ziaie,et al.  Polymeric microdevices for transdermal and subcutaneous drug delivery. , 2012, Advanced drug delivery reviews.

[11]  Z. Ahmad,et al.  Smart microneedle coatings for controlled delivery and biomedical analysis , 2014, Journal of drug targeting.

[12]  M. Toralles,et al.  Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development. , 2016, Environmental toxicology and pharmacology.

[13]  R. Rao,et al.  Sonophoresis: recent advancements and future trends , 2009, The Journal of pharmacy and pharmacology.

[14]  Akira Yamamoto,et al.  The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  J. Stockman,et al.  Dissolving polymer microneedle patches for influenza vaccination , 2012 .

[16]  Akira Yamamoto,et al.  Improvement of Transdermal Delivery of Exendin-4 Using Novel Tip-Loaded Microneedle Arrays Fabricated from Hyaluronic Acid. , 2016, Molecular pharmaceutics.

[17]  W. Paterson,et al.  Upper gastrointestinal toxicity of alendronate , 2000, American Journal of Gastroenterology.

[18]  P. Uzor,et al.  Perspectives on Transdermal Drug Delivery , 2011 .

[19]  R. Russell,et al.  Bisphosphonates: Mode of Action and Pharmacology , 2007, Pediatrics.

[20]  Muhammad Sohail Arshad,et al.  Microneedle Coating Techniques for Transdermal Drug Delivery , 2015, Pharmaceutics.

[21]  Kiyoshi Yamaoka,et al.  Statistical moments in pharmacokinetics , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[22]  K. Sugibayashi,et al.  Iontophoresis-Facilitated Delivery of Prednisolone through Throat Skin to the Trachea After Topical Application of its Succinate Salt , 2011, Pharmaceutical Research.

[23]  L. Simon,et al.  Modelling of dissolving microneedles for transdermal drug delivery: theoretical and experimental aspects. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  Absorption Enhancers: Applications and Advances , 2012, The AAPS Journal.

[25]  J. Mönkkönen,et al.  Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. , 2001, Bone.

[26]  G. Rodan,et al.  Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. , 2001, Molecular pharmacology.

[27]  Akira Yamamoto,et al.  Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  N. Dixit,et al.  Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.

[29]  Koen van der Maaden,et al.  Microneedle technologies for (trans)dermal drug and vaccine delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Jung-Hwan Park,et al.  Considerations in the use of microneedles: pain, convenience, anxiety and safety , 2017, Journal of drug targeting.

[31]  Praveen Kumar,et al.  Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: A patient friendly approach to manage arthritis , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  H. Kikkawa,et al.  Analysis of Change Patterns of Microcomputed Tomography 3-Dimensional Bone Parameters as a High-Throughput Tool to Evaluate Antiosteoporotic Effects of Agents at an Early Stage of Ovariectomy-Induced Osteoporosis in Mice , 2006, Investigative radiology.

[33]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[34]  L. Lichtenberger,et al.  Effect of Bisphosphonates on Surface Hydrophobicity and Phosphatidylcholine Concentration of Rodent Gastric Mucosa , 2000, Digestive Diseases and Sciences.